FIBROCELL® is an autologous treatment method based on the injection of fibroblast cells obtained from one’s own tissues into the region where one needs in a high-tech laboratory environment by bioengineering techniques.
FIBROCELL® is made up of person’s own fibroblast cells that produce the constituent proteins of skin such as collagen, elastin and hyaluronic acid in the purest and natural way.
FIBROCELL® is manufactured personally for the treatment of chronic wounds, as well as for the removal of deep lines on the skin due to age-related aging, known in the media and in the provision of skin tissue regeneration.
FIBROCELL® is the first autologous cellular therapy approved by the FDA.
* FIBROCELL® belongs to DOKU BİYOTEKNOLOJİ CO. LTD. And it is the first and only registrated autologous fibroblast cell brand in Turkey.
Physician, under local anesthesia , receives 1-2 pieces biopsies, preferably lentil size from behind the ear. Biopsy specimens with blood samples are placed in FIBROCELL® cold chain conveyor boxes and delivered to the DOKU Laboratory at 2-8 ° C.
| In GMP approved zero particle laboratory with high technology system, the proliferation of millions of new fibroblast cells is ensured. This is done with the FDA approval within critical processes specific to FIBROCELL® production technology. The produced fibroblast cells are ready for implementation through the quality control processes specified by the Ministry of Health and the European Standard. |
| The patient comes to the clinic then, the skin is numbed with topical anesthetic creams. FIBROCELL® is injected into the desired area of the patient. FIBROCELL® application consists of 3 sessions. The first session will be ready after about 4-6 weeks after the biopsy, second and third of the sessions are conducted with intervals of 2-3 weeks. The effect of FIBROCELL starts at second month and continues increasingly. According to the research, it has been shown the activity continues up to 5 years. |
FIBROCELL application is basically increasing the concentration per unit area by placing fibroblasts that produce extracellular matrix proteins, which are known to be effective in dermal regeneration, especially collagen and elastin, into the skin. However, it should be known that the person’s condition, age, genetic predispositions, lifestyle, food consumption habits and many other factors will affect the success of this application, and the application decision must be made as a result of a doctor’s evaluation.
All information on the website is for informational purposes. In addition to the explanations, the pages contain a reference list containing scientific and clinical studies. The use of any product or products is decided by the person who wants to have the cellular application and the doctor who will perform the application.
Tissue Biotechnology Stem Cell, Biobank and Tissue Engineering Center, as a facility authorized by the Ministry of Health and holding permits in this context, is required to produce cellular products in accordance with national/international norms and GMP requirements, to perform quality analyses, to store and to perform applications for the recipient. and is obliged to deliver the cellular product to the doctor who gives consent. Application process; It must be performed by the doctor under appropriate clinical conditions, with the technique and duration appropriate to the indication based on scientific and clinical data in the world, and within the framework of the law and professional ethical rules. At this point, responsibility; It is up to the person who is treated, then the practitioner and/or the application center official and the local supervisory health authority.
